MedTrace Logo

Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction

NCT03470532 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-03-21

No results posted yet for this study

Summary

This study compares the the efficacy of buccal infiltration of 4% Articaine and 2% Mepivacaine without any palatal injection during extraction of maxillary teeth. One group of patient receives buccal infiltration of Articaine and another group receives buccal infiltration of Mepivacaine.

Conditions

Interventions

DRUG

buccal infiltration of 4% Articaine with Epinephrine

Articaine Hydrochloride 4 % / Epinephrine 1:200,000 1.8 ML Cartridge

DRUG

buccal infiltration of 2% Mepivacaine with Epinephrine

Mepivacaine Hydrochloride 2% Epinephrine 1:200,000 2.2 Ml Cartridge

Sponsors & Collaborators

  • Melaka Manipal Medical College

    lead OTHER

Principal Investigators

  • Abdul k Azad, MDS · Melaka Manipal Medical College,Faculty of Dentistry, Manipal Academy of Higher Education

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-25
Primary Completion
2018-03-01
Completion
2018-03-01
FDA Drug
Yes

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470532 on ClinicalTrials.gov